Home
Conditions
Hepatic Impairment

Clinical trial condition

Hepatic Impairment

Explore clinical trials studying Hepatic Impairment. Study availability and eligibility vary by location and protocol.

237 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Hepatic Impairment trial results

Completed

KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

NCT04166942

Conditions: Hepatic Impairment
Locations: Inland Empire Clinical Trials, LLC-HQ Rialto, California, United States

Clinical Pharmacology of Miami Miami, Florida, United States

Advanced Pharma CR, LLC Miami, Florida, United States

Omega Research Group Orlando, Florida, United States

View Trial Details

Completed

Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects

NCT05391724

Conditions: Hepatic Impairment
Locations: Elite Research Miami, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

DaVita Clinical Research Minneapolis, Minnesota, United States

View Trial Details

Completed

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

NCT04752540

Conditions: Hepatic Impairment
Locations: Orange County Research Centre Tustin, California, United States

Orlando Clinical Research Centre Orlando, Florida, United States

View Trial Details

Completed

Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment

NCT02581592

Conditions: Digestive System Diseases, Fibrosis, Hepatic Impairment, +5 more
Locations: Orlando Clinical Research Center (OCRD) Orlando, Florida, United States

View Trial Details

Completed

A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment

NCT05112419

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hepatic Impairment, +6 more
Locations: Research Site Sofia, Bulgaria

View Trial Details

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

NCT03706898

Conditions: HIV-1-infection, Hepatic Impairment
Locations: Regional State Budgetary Healthcare Institution "Smolensk Regional Clinical Hospital" Smolensk, Russia

View Trial Details

Completed

A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment

NCT04225936

Conditions: Hepatic Impairment
Locations: The Texas Liver Institute San Antonio, Texas, United States

View Trial Details

Completed

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

NCT04293029

Conditions: Hepatic Impairment
Locations: The First Affiliated Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its Metabolite

NCT03968848

Conditions: Digestive System Diseases, Healthy Subjects, Hepatic Impairment, +2 more
Locations: Research Site Miami, Florida, United States

Research Site Orlando, Florida, United States

Research Site Knoxville, Tennessee, United States

View Trial Details

Completed

Study of Danicopan in Participants With Hepatic Impairment

NCT03555539

Conditions: Hepatic Impairment
Locations: Clinical Trial Site Miami, Florida, United States

Clinical Trial Site Orlando, Florida, United States

View Trial Details

Hepatic Impairment

Hepatic Impairment trial results

Related conditions